Lycopodium Limited

ASX:LYL.AX

12.65 (AUD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) AUD.

2024202320222021202020192018201720162015201420132012201120102009200820072006200520042003
Revenue 344.549323.879228.711158.063206.656152.223192.647216.616124.46122.811154.766244.996230.98168.589119.652145.969119.633103.75383.40468.14253.07730.119
Cost of Revenue 264.601243.534186.334115.069182.319122.71138.493184.205102.722109.538131.8485.6660.8390.2170.4180.6260.4230.1460.9591.1441.0672.203
Gross Profit 79.94880.34542.37742.99424.33629.51354.15432.41121.73813.27322.918239.33230.141168.372119.234145.343119.21103.60682.44566.99852.0127.916
Gross Profit Ratio 0.2320.2480.1850.2720.1180.1940.2810.150.1750.1080.1480.9770.9960.9990.9970.9960.9960.9990.9890.9830.980.927
Reseach & Development Expenses 0000000000000000000000
General & Administrative Expenses 127.851115.76786.97763.66768.19174.78676.1469.95165.93673.42899.898136.776128.37697.45572.09475.67359.9841.38140.31432.07323.77215.403
Selling & Marketing Expenses -103.031-97.215-71.09-49.211-55.45-66.675-67.563-61.898-57.854-65.367-92.36500000000000
SG&A 24.8218.55215.88714.45612.7418.1118.5778.0528.0828.0617.534136.776128.37697.45572.09475.67359.9841.38140.31432.07323.77215.403
Other Expenses 8.699-4.8899.836-10.0050.68213.361-12.080.1590.2590.4221.304-0.2210.0830.0030.5020.1730.2650.2690.3430.366-0.033-0.039
Operating Expenses 16.12123.4416.05124.46112.0597.70730.16218.0116.48914.83515.09216.898199.624144.44100.982128.626102.38292.04472.55559.86544.27225.65
Operating Income 63.82756.90436.32618.53212.2777.78536.05513.6474.558-4.0334.75723.37630.51723.93218.25216.71716.82811.5629.897.1337.7382.266
Operating Income Ratio 0.1850.1760.1590.1170.0590.0510.1870.0630.037-0.0330.0310.0950.1320.1420.1530.1150.1410.1110.1190.1050.1460.075
Total Other Income Expenses Net 3.3964.3092.8021.8143.26315.759-10.30.6610.6572.4132.9255.4040.3630.0030.5283.1670.3090.3530.3430.366-0.033-0.039
Income Before Tax 67.22361.21439.12820.34615.5423.54425.75514.3085.216-1.627.68328.53431.77224.90818.71220.20317.66512.40610.6167.7327.562.09
Income Before Tax Ratio 0.1950.1890.1710.1290.0750.1550.1340.0660.042-0.0130.050.1160.1380.1480.1560.1380.1480.120.1270.1130.1420.069
Income Tax Expense 18.80317.71812.0757.4236.7747.1457.0973.9341.8890.6053.9735.9949.4177.7952.6535.4255.1883.5093.0227.7327.562.09
Net Income 50.71446.7827.17814.19911.80416.50718.1710.2923.163-0.9183.87921.93222.14317.16216.05814.1712.4778.8987.594-0.226-0.2040.065
Net Income Ratio 0.1470.1440.1190.090.0570.1080.0940.0480.025-0.0070.0250.090.0960.1020.1340.0970.1040.0860.091-0.003-0.0040.002
EPS 1.281.180.680.360.30.420.460.260.08-0.0230.10.560.570.440.420.370.330.240.2-0.007-0.0060.033
EPS Diluted 1.281.180.680.350.30.420.460.260.08-0.0230.0980.550.560.440.410.370.330.240.2-0.007-0.0060.033
EBITDA 70.39863.27141.94723.31720.3099.03637.10114.5365.476-2.7536.5430.95833.88626.44721.03519.51919.38213.68411.6969.0368.4062.857
EBITDA Ratio 0.2040.1950.1830.1480.0980.0590.1930.0670.044-0.0220.0420.1260.1470.1570.1760.1340.1620.1320.140.1330.1580.095